Moderna (MRNA) Debt/EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 6.30 | -0.79 | -0.90 | -1.01 | 2.24 | 0.15 | |||
Changes by years, y/y, % | +194% | -113% | +13% | +13% | -321% | -11.0% |
Moderna. Debt/EBITDA
Moderna. Debt/EBITDA, changes, %
Moderna (MRNA) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Debt/EBITDA | 3.47 | 2.42 | 1.94 | 2.05 | 0.15 | 0.15 | ||
Changes by years, y/y, % | -766% | -370% | -223% | -121% | -96% | |||
Changes by quarters, q/q, % | +422% | -30% | -20% | +5% | -93% |